US tackles confusion over tissue and device classifications
This article was originally published in Clinica
Executive Summary
The US FDA needs to define more clearly what categories of products it considers to be human tissue and what it considers to be devices, representatives from tissue banks and the orthopaedics industry told the agency earlier this month.